Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 9802-9816

  Norström, Melissa M ^a   Buggert, Marcus ^a   Tauriainen, Johanna ^a   Hartogensis, Wendy ^b   Prosperi, Mattia C ^c   Wallet, Mark A ^c   Hecht, Frederick M ^b   Salemi, Marco ^c,d   Karlsson, Annika C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN; INTERLEUKIN 2;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA FLANKING REGION; FEMALE; FLOW CYTOMETRY; GENETIC DRIFT; GENETIC SELECTION; HIGH RISK PATIENT; HOMOPLASY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION RISK; MALE; MOLECULAR CLOCK; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SYNDROME DELINEATION; UNINDEXED SEQUENCE; WILD TYPE;

CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RISK FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866150144     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01165-12     Document Type: Article

References (80)

1. Akinsiku OT, Bansal A, Sabbaj S, Heath SL, Goepfert PA. 2011. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression J. Acquir. Immune Defic. Syndr. 58:132-140.
2. Almeida JR, et al. 2007. Superior control of HIV-1 replication by CD8 + T cells is reflected by their avidity, polyfunctionality, and clonal turnover J. Exp. Med. 204:2473-2485.
3. Bailey JR, Williams TM, Siliciano RF, Blankson JN. 2006. Maintenance of viral suppression in HIV-1-infected HLA-B*57 + elite suppressors despite CTL escape mutations J. Exp. Med. 203:1357-1369.
4. Bailey JR, et al. 2007. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape J. Infect. Dis. 196:50-55.
5. Betts MR, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8 + T cells Blood 107:4781-4789.
6. Blankson J, Persaud D, Siliciano RF. 1999. Latent reservoirs for HIV-1 Curr. Opin. Infect. Dis. 12:5-11.
7. Borghans JA, Molgaard A, de Boer RJ, Kesmir C. 2007. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2: e920. doi:10.1371/journal.pone.0000920.
8. Brockman MA, et al. 2007. Escape and compensation from early HLAB57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A J. Virol. 81:12608-12618.
9. Bruen TC, Philippe H, Bryant D. 2006. A simple and robust statistical test for detecting the presence of recombination Genetics 172:2665-2681.
10. Brumme ZL, et al. 2008. Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection J. Virol. 82:9216-9227.
11. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection N. Engl. J. Med. 332:201-208.
12. Cellerai C, et al. 2010. Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7Rα (CD127) and perforin expression J. Virol. 84:3868-3878.
13. de Oliveira T, et al. 2005. An automated genotyping system for analysis of HIV-1 and other microbial sequences Bioinformatics 21:3797-3800.
14. Dinges WL, et al. 2010. Virus-specific CD8 + T-cell responses better define HIV disease progression than HLA genotype J. Virol. 84:4461-4468.
15. Draenert R, et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection J. Exp. Med. 199:905-915.
16. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4: e88. doi:10.1371/journal.pbio.0040088.
17. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. [Epub ahead of print.] doi:10.1093/molbev/mss075.
18. Durand CM, et al. 2010. HIV-1 Gag evolution in recently infected human leukocyte antigen-B*57 patients with low-level viremia AIDS 24:2405-2408.
19. Ferrari G, et al. 2011. Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog. 7: e1001273. doi:10.1371/journal.ppat.1001273.
20. Fiebig EW, et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection AIDS 17:1871-1879.
21. Friedrich TC, et al. 2007. Subdominant CD8 + T-cell responses are involved in durable control of AIDS virus replication J. Virol. 81:3465-3476.
22. Gao X, et al. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis Nat. Med. 11:1290-1292.
23. Goonetilleke N, et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection J. Exp. Med. 206:1253-1272.
24. Goudsmit J, et al. 2002. Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia AIDS 16:791-793.
25. Goulder PJ, et al. 2001. Substantial differences in specificity of HIVspecific cytotoxic T cells in acute and chronic HIV infection J. Exp. Med. 193:181-194.
26. Goulder PJ, et al. 1996. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection AIDS Res. Hum. Retrovir. 12:1691-1698.
27. Grenfell BT, et al. 2004. Unifying the epidemiological and evolutionary dynamics of pathogens Science 303:327-332.
28. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood Syst. Biol. 52:696-704.
29. Hecht FM, et al. 2002. Use of laboratory tests and clinical symptoms for identification of primary HIV infection AIDS 16:1119-1129.
30. Hecht FM, et al. 2011. Identifying the early post-HIV antibody seroconversion period J. Infect. Dis. 204:526-533.
31. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies Mol. Biol. Evol. 23:254-267.
32. Karlsson AC, et al. 2007. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS One 2:e225. doi: 10.1371/journal.pone.0000225.
33. Kearney M, et al. 2008. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase AIDS 22:497-501.
34. Kimura M. 1983. The neutral theory of molecular evolution. Cambridge University Press, Cambridge, MA.
35. Lefrere JJ, et al. 1997. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection Blood 90:1133-1140.
36. Lemey P, et al. 2007. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput. Biol. 3:e29. doi:10.1371/journal.pcbi.0030029.
37. Leslie A, et al. 2005. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA J. Exp. Med. 201:891-902.
38. Leslie AJ, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission Nat. Med. 10:282-289.
39. Lindkvist A, et al. 2009. Reduction of the HIV-1 reservoir in resting CD4 + T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study. AIDS Res. Ther. 6: 15.
40. Lyles RH, et al. 2000. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J. Infect. Dis. 181:872-880.
41. Makedonas G, et al. 2009. Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8 + T cell cytotoxic activity J. Immunol. 182:5560-5569.
42. Makedonas G, Betts MR. 2011. Living in a house of cards: re-evaluating CD8+T-cell immune correlates against HIV Immunol. Rev. 239:109-124.
43. Makedonas G, et al. 2010. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog. 6: e1000798.
44. Martinez-Picado J, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J. Virol. 80:3617-3623.
45. Mellors JW, et al. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection Ann. Intern. Med. 126:946-954.
46. Mendoza D, et al. 2012. HLA B*5701-positive long-term nonprogressors/ elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells J. Virol. 86:4014-4018.
47. Migueles SA, Connors M. 2001. Frequency and function of HIV-specific CD8(+) T cells Immunol. Lett. 79:141-150.
48. Migueles SA, Connors M. 2010. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV JAMA 304:194-201.
49. Migueles SA, et al. 2003. The differential ability of HLA B*5701 + longterm nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences J. Virol. 77:6889-6898.
50. Migueles SA, et al. 2002. HIV-specific CD8 + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors Nat. Immunol. 3:1061-1068.
51. Migueles SA, et al. 2008. Lytic granule loading of CD8+T cells is required for HIV-infected cell elimination associated with immune control Immunity 29:1009-1021.
52. Migueles SA, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors Proc. Natl. Acad. Sci. U. S. A. 97:2709-2714.
53. Miura T, et al. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition J. Virol. 83:2743-2755.
54. Munoz A, et al. 1995. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+lymphocytes J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:496-505.
55. Navis M, et al. 2007. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection J. Immunol. 179:3133-3143.
56. Nei M, Gojobori T. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions Mol. Biol. Evol. 3:418-426.
57. Nielsen R, Yang Z. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene Genetics 148:929-936.
58. O'Brien TR, et al. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study JAMA 276:105-110.
59. O'Connell KA, et al. 2010. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus J. Virol. 84:7018-7028.
60. Palmer S, et al. 2005. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis J. Clin. Microbiol. 43:406-413.
61. Pantaleo G, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection N. Engl. J. Med. 332:209-216.
62. Pereyra F, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation Science 330:1551-1557.
63. Peters HO, et al. 2008. An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort J. Virol. 82:1980-1992.
64. Riou C, et al. 2012. Distinct kinetics of Gag-specific CD4 + and CD8 + T cell responses during acute HIV-1 infection J. Immunol. 188:2198-2206.
65. Rodes B, et al. 2004. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection AIDS 18:1109-1116.
66. Roederer M, Nozzi JL, Nason MC. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets Cytometry A 79:167-174.
67. Salemi M, et al. 2007. Phylodynamics of HIV-1 in lymphoid and nonlymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. PLoS One 2:e950. doi:10.1371/journal.pone.0000950.
68. Salemi M, Gray RR, Goodenow MM. 2008. An exploratory algorithm to identify intra-host recombinant viral sequences Mol. Phylogenet. Evol. 49:618-628.
69. Schmidt HA, Strimmer K, Vingron M, von Haeseler A. 2002. TREEPUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing Bioinformatics 18:502-504.
70. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. 1993. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels AIDS 7:1159-1166.
71. Strimmer K, von Haeseler A. 1997. Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment Proc. Natl. Acad. Sci. U. S. A. 94:6815-6819.
72. Swanson WJ, Nielsen R, Yang Q. 2003. Pervasive adaptive evolution in mammalian fertilization proteins Mol. Biol. Evol. 20:18-20.
73. Swofford DL, Sullivan J. 2009. Phylogeny inference based on parsimony and other methods using PAUP*, p 289-312. In Lemey P, Salemi M, Vandamme A-M (ed), The phylogenetic handbook: a practical approach to phylogenetic analysis and hypothesis testing. Cambridge University Press, Cambridge, MA.
74. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods Mol. Biol. Evol. 28:2731-2739.
75. Tang Y, et al. 2010. Correlates of spontaneous viral control among longterm survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57 AIDS 24:1425-1435.
76. Troyer RM, et al. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 5: e1000365. doi:10.1371/journal.ppat.1000365.
77. Wong WS, Yang Z, Goldman N, Nielsen R. 2004. Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites Genetics 168:1041-1051.
78. Yang Z. 2000. Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A J. Mol. Evol. 51:423-432.
79. Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood Mol. Biol. Evol. 24:1586-1591.
80. Zimmerli SC, et al. 2005. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells Proc. Natl. Acad. Sci. U. S. A. 102:7239-7244.